Tiemann Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.05M | Buy |
2,234
+435
| +24% | +$441K | 0.81% | 26 |
|
|
2025
Q4 | $1.93M | Sell |
1,799
-8
| -0.4% | -$7.65K | 0.75% | 29 |
|
|
2025
Q3 | $1.38M | Sell |
1,807
-35
| -2% | -$26K | 0.53% | 41 |
|
|
2025
Q2 | $1.44M | Hold |
1,842
| – | – | 0.59% | 38 |
|
|
2025
Q1 | $1.52M | Buy |
1,842
+5
| +0.3% | +$4.16K | 0.69% | 31 |
|
|
2024
Q4 | $1.42M | Sell |
1,837
-30
| -2% | -$24.8K | 0.63% | 37 |
|
|
2024
Q3 | $1.65M | Sell |
1,867
-113
| -6% | -$102K | 0.71% | 33 |
|
|
2024
Q2 | $1.79M | Sell |
1,980
-27
| -1% | -$21.6K | 0.8% | 29 |
|
|
2024
Q1 | $1.56M | Buy |
2,007
+25
| +1% | +$17.8K | 0.7% | 34 |
|
|
2023
Q4 | $1.16M | Sell |
1,982
-19
| -0.9% | -$11.1K | 0.56% | 41 |
|
|
2023
Q3 | $1.07M | Sell |
2,001
-1
| -0% | -$515 | 0.57% | 41 |
|
|
2023
Q2 | $939K | Buy |
2,002
+10
| +0.5% | +$4.19K | 0.48% | 53 |
|
|
2023
Q1 | $684K | Buy |
1,992
+85
| +4% | +$28.7K | 0.37% | 63 |
|
|
2022
Q4 | $698K | Buy |
1,907
+125
| +7% | +$44.3K | 0.41% | 62 |
|
|
2022
Q3 | $576K | Sell |
1,782
-45
| -2% | -$14.3K | 0.37% | 59 |
|
|
2022
Q2 | $592K | Buy |
1,827
+82
| +5% | +$24.6K | 0.32% | 71 |
|
|
2022
Q1 | $500K | Buy |
1,745
+35
| +2% | +$9.01K | 0.23% | 93 |
|
|
2021
Q4 | $472K | Sell |
1,710
-50
| -3% | -$12.7K | 0.2% | 114 |
|
|
2021
Q3 | $407K | Sell |
1,760
-50
| -3% | -$12.3K | 0.19% | 119 |
|
|
2021
Q2 | $415K | Sell |
1,810
-10
| -0.5% | -$2.01K | 0.19% | 125 |
|
|
2021
Q1 | $340K | Sell |
1,820
-83
| -4% | -$16.2K | 0.17% | 140 |
|
|
2020
Q4 | $321K | Hold |
1,903
| – | – | 0.17% | 136 |
|
|
2020
Q3 | $282K | Sell |
1,903
-25
| -1% | -$3.87K | 0.17% | 138 |
|
|
2020
Q2 | $317K | Buy |
1,928
+329
| +21% | +$50.5K | 0.22% | 119 |
|
|
2020
Q1 | $222K | Hold |
1,599
| – | – | 0.19% | 137 |
|
|
2019
Q4 | $210K | Sell |
1,599
-275
| -15% | -$31.9K | 0.14% | 176 |
|
|
2019
Q3 | $210K | Sell |
1,874
-275
| -13% | -$30.6K | 0.15% | 170 |
|
|
2019
Q2 | $238K | Hold |
2,149
| – | – | 0.17% | 157 |
|
|
2019
Q1 | $279K | Hold |
2,149
| – | – | 0.21% | 129 |
|
|
2018
Q4 | $249K | Hold |
2,149
| – | – | 0.22% | 135 |
|
|
2018
Q3 | $231K | Buy |
+2,149
| New | +$215K | 0.18% | 158 |
|
|
2017
Q2 | – | Sell |
-2,599
| Closed | -$219K | – | 164 |
|
|
2017
Q1 | $219K | Hold |
2,599
| – | – | 0.2% | 149 |
|
|
2016
Q4 | $191K | Hold |
2,599
| – | – | 0.19% | 154 |
|
|
2016
Q3 | $209K | Hold |
2,599
| – | – | 0.19% | 157 |
|
|
2016
Q2 | $205K | Buy |
+2,599
| New | +$196K | 0.19% | 155 |
|
|
2016
Q1 | – | Sell |
-2,824
| Closed | -$238K | – | 154 |
|
|
2015
Q4 | $238K | Sell |
2,824
-1,000
| -26% | -$83K | 0.24% | 133 |
|
|
2015
Q3 | $320K | Buy |
3,824
+200
| +6% | +$16.9K | 0.35% | 92 |
|
|
2015
Q2 | $303K | Sell |
3,624
-75
| -2% | -$5.71K | 0.31% | 106 |
|
|
2015
Q1 | $269K | Buy |
3,699
+25
| +0.7% | +$1.78K | 0.28% | 118 |
|
|
2014
Q4 | $253K | Buy |
3,674
+50
| +1% | +$3.38K | 0.27% | 121 |
|
|
2014
Q3 | $235K | Hold |
3,624
| – | – | 0.26% | 124 |
|
|
2014
Q2 | $225K | Buy |
3,624
+75
| +2% | +$4.47K | 0.25% | 127 |
|
|
2014
Q1 | $209K | Buy |
+3,549
| New | +$198K | 0.23% | 139 |
|
Other funds holding LLY
VCM
VPM
Tiemann Investment Advisors's LLY Position: Q1 2026 in Review
Tiemann Investment Advisors increased its Eli Lilly (LLY) stake by 24% in Q1 2026, buying an estimated $441K and bringing the position to 2,234 shares worth $2.05M. The position accounts for 0.81% of the portfolio, ranked #26.
Tiemann Investment Advisors first reported a position in LLY in Q1 2014 and has held it in 43 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tiemann Investment Advisors held 2,234 shares of Eli Lilly worth $2.05M as of Q1 2026.
- Tiemann Investment Advisors bought 435 Eli Lilly shares in Q1 2026, an estimated $441K.
- Eli Lilly made up 0.81% of Tiemann Investment Advisors's portfolio in Q1 2026, its #26 holding.
- Tiemann Investment Advisors first reported a position in Eli Lilly in Q1 2014 and has held it in 43 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tiemann Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.